Colestasis asociada a tratamiento con pregabalina
Crespo Pérez, Laura; Moreira Vicente, Víctor; Manzano Fernández, Rebeca; García Aguilera, Xavier Arturo.
Med. clín (Ed. impr.)
; 130(4): 157-158, feb. 2008.
Artículo en Es | IBECS (España) | ID: ibc-63495
Documentos relacionados
Integrating Mechanistic and Toxicokinetic Information in Predictive Models of Cholestasis.
[Cholestasis associated with pregabalin treatment].
Population pharmacokinetic model to generate mechanistic insights in bile acid homeostasis and drug-induced cholestasis.
Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics.
Optimization of an adverse outcome pathway network on chemical-induced cholestasis using an artificial intelligence-assisted data collection and confidence level quantification approach.
Cloxacillin-induced acute vanishing bile duct syndrome: A case study and literature review.
A Case of Daptomycin-Induced Acute Cholestatic Hepatic Injury With Fatal Outcomes.
Molecular and Clinical Links between Drug-Induced Cholestasis and Familial Intrahepatic Cholestasis.
Silymarin protects the liver from α-naphthylisothiocyanate-induced cholestasis by modulating the expression of genes involved in bile acid homeostasis.
Effects of Yinzhihuang on Alleviating Cyclosporine A-Induced Cholestatic Liver Injury via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Vitro and in Vivo.